Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the small volume parenteral market right now?

The market size for small volume parenteral has seen substantial growth in recent times. The market will rise from $177.26 billion in 2024 to an estimated $193.16 billion in 2025, expanding at a compound annual growth rate (CAGR) of 9.0%. Factors contributing to growth during the historic period include the increasing occurrence of chronic diseases, government approvals and initiatives, trends in pharmaceutical outsourcing, as well as globalization and the broadening of pharmaceutical markets.

How fast Is the small volume parenteral market expected to grow, and what’s its future value?

The small volume parenteral market size is expected to see strong growth in the next few years. It will grow to $268.53 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the expansion of the biologics market, healthcare infrastructure development, increased hospitalization rates, regulatory approvals, a shift toward home healthcare, rising investment in healthcare, and global health crises. Major trends in the forecast period include growth in biocompatible formulations, patient-centric approaches, rise in home healthcare, advancements in manufacturing automation, expansion in therapeutic areas, and smart pump technologies.

Get your small volume parenteral market report here!

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

What are the leading drivers of growth in the small volume parenteral market?

The growth of the small-volume parenteral market is likely to be fueled by the rising number of surgeries. A medical area of specialization, surgery employs operative methodologies to diagnose or treat pathological conditions such as diseases or injuries. Surgical requirements are on the upswing due to advancements in medical tech and a growing older population, consequently driving the demand for surgical interventions. The use of small-volume parenteral solutions in surgeries is indispensable for the exact administration of medications, vitamins, and electrolytes directly into the bloodstream. The Aesthetic Society, an American plastic surgery and cosmetic medicine organization, reported that in August 2023, over $11.8 billion was spent on aesthetic procedures, reflecting a 2% rise from the previous year. As such, the escalating number of surgeries is bolstering the growth of the small-volume parenteral market.

What are the key segments defining the small volume parenteral market?

The small volume parenteral market covered in this report is segmented –

1) By Type: Ampules, Vials, Prefilled Syringes

2) By Dose Type: Single Dose, Multiple Dose

3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications

4) By Application: Local Anesthetics, Vaccines, Other Applications

5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users

Subsegments:

1) By Ampules: Glass Ampules, Plastic Ampules

2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials

3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp

Who are the key firms paving the way for growth in the small volume parenteral market?

Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc., Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

How are evolving market trends shaping small volume parenteral Strategies?

Primary players in the small volume parenteral market, such as WuXi STA, are increasing their focus on establishing innovative solutions like the built-in lyophilizer to boost their market revenues. This integrated system, the built-in lyophilizer, is part of the manufacturing pipeline responsible for freezing and drying products to produce lyophilized powders. These powders are frequently used in specific parenteral drugs. In a recent development in January 2022, WuXi STA, a pharmaceutical organization based in China, introduced a new parenteral formulation production line. This production line, coupled with the sterile manufacturing plant in Wuxi, adheres to cGMP guidelines mandated by regulatory bodies [the U.S. FDA, EMA, and China NMPA]. This brand-new line features state-of-the-art isolation systems and filling apparatus in the sector. All filling processes are robotically executed within a fully isolated setup, specifically designed to minimize human interaction and prevent contamination, thereby maintaining high-quality product standards.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15925

Which regions are emerging as leaders in the small volume parenteral market?

North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Volumetric Video Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/volumetric-video-global-market-report

Volumetric Display Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/volumetric-display-global-market-report

Self-Administered Parenteral Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: